Drug Type Small molecule drug |
Synonyms (7E)-19-Nor-9,10-seco-14beta-cholesta-5,7-dien-23-yne-1alpha,3beta,25-triol |
Target |
Mechanism VDR agonists(Vitamin D receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
RegulationOrphan Drug (EU) |
Molecular FormulaC26H40O3 |
InChIKeyHHGRMHMXKPQNGF-WNSNRMDMSA-N |
CAS Registry163217-09-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 2 | - | - | |
Acute Myeloid Leukemia | Phase 2 | - | - | |
Chronic Lymphocytic Leukemia | Phase 2 | - | - | |
Chronic Lymphocytic Leukemia | Phase 2 | FR | - | |
Philadelphia chromosome positive chronic myelogenous leukemia | Phase 2 | - | - | |
Prostatic Cancer | Phase 2 | - | - | |
Psoriasis | Phase 2 | - | - | - |
Psoriasis | Phase 2 | - | - | |
Psoriasis | Phase 2 | FR | - | |
Psoriasis | Phase 2 | US | - | - |
Phase 2 | 54 | (rdpzjcubpg) = fcpjgkfnqr kmytslppgg (hbsjzssnfz ) | - | 20 May 2011 | |||
Phase 2 | 54 | (kjzsxuvirr) = fmbjrpfjri ixoxeuccez (onxyinlxuv ) View more | Positive | 01 Apr 2011 | |||
Phase 2 | 54 | (kyfwjmwous) = ehgjfmzppd oiiqxylrkl (kfixszpmlk ) View more | - | 01 Mar 2011 |